Engineering adoptive T cell therapy to co-opt Fas ligand-mediated death signaling in ovarian cancer enhances therapeutic efficacy by Philip D Greenberg, Kristin G Anderson, Shannon K Oda, Breanna M Bates, Madison G Burnett, Magdalia Rodgers Suarez, Susan L Ruskin

Get full text

Intentional heterogeneity in autologous cell-based gene therapies: strategic considerations for first-in-human trials by Antoni Ribas, Carl H June, Philip D Greenberg, Crystal L Mackall, Marcela V Maus, John E Connolly, Christopher R Cabanski, Ute Dugan, Mark D Stewart, Jeff D Allen, EnJun Yang, Alexander Marson

Get full text

A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards... by Francesco Mazziotta, Lauren E. Martin, Daniel N. Egan, Merav Bar, Sinéad Kinsella, Kelly G. Paulson, Valentin Voillet, Miranda C. Lahman, Daniel Hunter, Thomas M. Schmitt, Natalie Duerkopp, Cecilia C. S. Yeung, Tzu-Hao Tang, Raphael Gottardo, Yuta Asano, Elise C. Wilcox, Bo Lee, Tianzi Zhang, Paolo Lopedote, Livius Penter, Catherine J. Wu, Filippo Milano, Philip D. Greenberg, Aude G. Chapuis

Get full text

APMAT analysis reveals the association between CD8 T cell receptors, cognate antigen, and T cell phenotype and persistence by Jingyi Xie, Daniel G. Chen, William Chour, Rachel H. Ng, Rongyu Zhang, Dan Yuan, Jongchan Choi, Michaela McKasson, Pamela Troisch, Brett Smith, Lesley Jones, Andrew Webster, Yusuf Rasheed, Sarah Li, Rick Edmark, Sunga Hong, Kim M. Murray, Jennifer K. Logue, Nicholas M. Franko, Christopher G. Lausted, Brian Piening, Heather Algren, Julie Wallick, Andrew T. Magis, Kino Watanabe, Phil Mease, Philip D. Greenberg, Helen Chu, Jason D. Goldman, Yapeng Su, James R. Heath

Get full text